A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer

被引：0
|
作者：
Yasuhide Yamada
Naomi Kiyota
Nozomu Fuse
Ken Kato
Hironobu Minami
Kensei Hashizume
Yoshihiro Kuroki
Yuichiro Ito
Atsushi Ohtsu
机构：
[1] National Cancer Center Hospital,Gastrointestinal Medical Oncology Division
[2] Kobe University Hospital,undefined
[3] National Cancer Hospital East,undefined
[4] National Cancer Center Hospital,undefined
[5] Bayer Yakuhin Ltd,undefined
[6] National Cancer Hospital,undefined
来源：
Gastric Cancer | 2014年 / 17卷
关键词：
Sorafenib; Phase I; S-1; Cisplatin; Gastric adenocarcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：161 / 172
页数：11
相关论文
共 50 条
  • [1] A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer
    Yamada, Yasuhide
    Kiyota, Naomi
    Fuse, Nozomu
    Kato, Ken
    Minami, Hironobu
    Hashizume, Kensei
    Kuroki, Yoshihiro
    Ito, Yuichiro
    Ohtsu, Atsushi
    GASTRIC CANCER, 2014, 17 (01) : 161 - 172
  • [2] A phase I study of sorafenib (BAY 43-9006) in combination with S-1 plus cisplatin in patients with advanced gastric cancer
    Yamada, Yasuhide
    Minami, Hironobu
    Fuse, Nozomu
    Ohtsu, Atsushi
    Kato, Ken
    Kiyota, Naomi
    Shimada, Yasushiro
    Doi, Toshihiko
    Nakajima, Takako
    Hamaguchi, Tetsuya
    Fujiwara, Yutaka
    Ito, Yuichiro
    Mera, Kiyomi
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [3] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [4] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
    Hosokawa, A.
    Ogawa, K.
    Kajiura, S.
    Tsukioka, Y.
    Kobayashi, T.
    Horikawa, N.
    Kobayashi, Y.
    Yoshioka, A.
    Sumi, S.
    Sugiyama, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [5] Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer
    Boku, Narikazu
    Muro, Kei
    Machida, Nozomu
    Hashigaki, Satoshi
    Kimura, Nobuyuki
    Suzuki, Mie
    Lechuga, Mariajose
    Miyata, Yoshinori
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 261 - 270
  • [6] Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer
    Narikazu Boku
    Kei Muro
    Nozomu Machida
    Satoshi Hashigaki
    Nobuyuki Kimura
    Mie Suzuki
    Mariajose Lechuga
    Yoshinori Miyata
    Investigational New Drugs, 2014, 32 : 261 - 270
  • [7] Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma
    Ajani, JA
    Faust, J
    Ikeda, K
    Yao, JC
    Anbe, H
    Carr, KL
    Houghton, M
    Urrea, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6957 - 6965
  • [8] Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Hironaka, Shuichi
    Yamazaki, Kentaro
    Taku, Keisei
    Yokota, Tomoya
    Shitara, Kohei
    Kojima, Takashi
    Ueda, Shinya
    Machida, Nozomu
    Muro, Kei
    Boku, Narikazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1014 - 1020
  • [9] A Phase I Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Kimura, Yutaka
    Yano, Hiroshi
    Imamura, Hiroshi
    Fujitani, Kazumasa
    Imano, Motohiro
    Tokunaga, Yukihiko
    Matsuoka, Masaki
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Takiuchi, Hiroya
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 125 - 131
  • [10] Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer
    Satoh, Taroh
    Yamada, Yasuhide
    Muro, Kei
    Hayashi, Hidetoshi
    Shimada, Yasuhiro
    Takahari, Daisuke
    Taku, Keisei
    Nakajima, Takako Eguchi
    Shi, Xiaojin
    Brown, Kathryn H.
    Boku, Narikazu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 439 - 446
12345